Efficiency of Importin alpha /beta -Mediated Nuclear Localization Sequence Recognition and Nuclear Import
DIFFERENTIAL ROLE OF NTF2*

Wei Hu and David A. JansDagger

From the Nuclear Signalling Laboratory, Division for Biochemistry and Molecular Biology, John Curtin School of Medical Research, Canberra, ACT 2601, Australia

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Little quantitative, kinetic information is available with respect to the process of nuclear import of conventional nuclear localization sequence (NLS)-containing proteins, which initially involves recognition and docking at the nuclear pore by importin alpha /beta . This study compares the binding and nuclear import properties of mouse (m) and yeast (y) importin (IMP) subunits with respect to the NLSs from the SV40 large tumor antigen (T-ag), and the Xenopus laevis phosphoprotein N1N2. m- and y-IMPalpha recognized both NLSs, with y-IMPalpha exhibiting higher affinity. m-IMPbeta greatly enhanced the binding of m-IMPalpha to the T-ag and N1N2 NLSs, but y-IMPbeta did not significantly affect the affinity of y-IMPalpha for the T-ag NLS. In contrast, y-IMPbeta enhanced y-IMPalpha binding to the NLS of N1N2, but to a lesser extent than the enhancement of m-IMPalpha binding by m-IMPbeta . NLS-dependent nuclear import was reconstituted in vitro using the different importin subunits together with the transport factors Ran and NTF2. Whereas T-ag NLS-mediated nuclear import did not exhibit an absolute requirement for NTF2, N1N2 NLS-mediated transport strictly required NTF2. High levels of NTF2 inhibited nuclear accumulation conferred by both NLSs. We conclude that different NLSs possess distinct nuclear import properties due to differences in recognition by importin and requirements for NTF2.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The entry of karyophilic proteins into the nucleus through the nuclear pore complex (NPC)1 is effected by specific targeting signals called nuclear localization sequences (NLSs) (1, 2), and is a receptor-mediated (3, 4), energy-dependent (5, 6) process. The key factors involved are members of the NLS-binding importin/karyopherin family (7-11), and the monomeric GTPase Ran/TC4 (12, 13) and auxiliary proteins such as NTF2/p10 (14, 15). In the first step, the NLS-containing protein is recognized by the importin heterodimer through the NLS-binding importin alpha  subunit (3, 7, 9), and then targeted to the NPC through the affinity of the importin beta  subunit (8, 10, 11, 16) for NPC components (17, 18). In the second step requiring cytoplasmic RanGDP (19, 20), the complex is translocated through the NPC (21) and importin alpha  and the NLS-containing protein released into the nucleus through the action of RanGTP (19). Alternative signal-mediated nuclear import pathways independent of the importin alpha /beta heterodimer have recently been identified where either importin beta  (22, 23) or importin beta -related homologs (24-26) appear to fulfil the role of both importin alpha  and beta  in binding NLSs and targeting them to the NPC (24, 25, 27).

Although NLS receptors from different species share structural and functional homology, the recognition of different types of NLS by importin subunits and its importance in the nuclear import process has not been adequately investigated in quantitative terms (28, 29). In this study, we compare the NLS binding and transport properties of mouse and yeast importin subunits. We find that although mouse (m-IMPalpha ) and yeast (y-IMPalpha ) importin alpha s can bind different types of NLS, y-IMPalpha binds with higher affinity. y-IMPbeta does not significantly affect the affinity of y-IMPalpha for the NLS of the simian virus SV40 large tumor antigen (T-ag) but does enhance binding to the NLS of the Xenopus laevis phosphoprotein N1N2. In contrast, m-IMPalpha requires m-IMPbeta for high affinity binding. Nuclear import of a T-ag-NLS containing fusion protein in vitro was found to be enhanced by NTF2 but did not require it absolutely, whereas import of an N1N2 NLS-containing fusion protein had an absolute requirement for NTF2. Surprisingly, high NTF2 concentrations inhibited nuclear import in all cases. The results indicate that different types of NLS have different requirements with respect to the factors mediating nuclear import, and imply a differential, regulatory role for NTF2 in nuclear transport.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Fusion Proteins-- The amino acid sequences of the NLSs used are shown in Table I. Constructs to express fusion proteins T-ag-CcN-beta -Gal, and the NLS-defective mutant derivative T-ag-Cc-beta -Gal containing T-ag sequences fused amino-terminal to the Escherichia coli beta -galactosidase sequence (amino acids 9-1023) have been described (30, 31). The plasmid pPR-N1N2-beta -Gal expressing Xenopus laevis N1N2 amino acids 465-581 fused amino-terminal to beta -galactosidase has been described (32). Plasmids encoding the N1N2 NLS-mutated derivatives N1N2A-beta -Gal and N1N2B-beta -Gal were derived through oligonucleotide site-directed mutagenesis (U.S.E. mutagenesis kit, Amersham Pharmacia Biotech) of plasmid pPR2-N1N2-beta -Gal. N1N2A-beta -Gal and N1N2B-beta -Gal possess Asn-Asn-Ser in place of Lys-Lys-Arg537 and Leu-Gln-Asn in place of the Ala-Lys-Lys552, respectively (see Table I).

beta -galactosidase fusion proteins were expressed, purified, and labeled with 5-iodoacetamidofluorescein as previously (30, 31). m-IMPalpha (PTAC58), m-IMPbeta (PTAC97), y-IMPalpha (Kap60), y-IMPbeta (Kap95) subunits, and human Ran were expressed as glutathione S-transferase (GST) fusion proteins and purified as described (9, 21, 28, 34). GST-free y-IMPbeta , m-IMPbeta , and Ran were prepared by thrombin cleavage (21, 22, 28, 34, 35). Ran was loaded with GDP as described (36). Recombinant human NTF2 was expressed and purified using S100 HR column chromatography as described (15). Protein concentrations were determined using the dye binding assay of Bradford (37), with bovine serum albumin as a standard.

ELISA-based Binding Assay-- An ELISA-based binding assay (28, 34, 35, 38) was used to examine the affinity of binding between importin subunits (with and without GST moieties) and NLS-containing proteins. The latter were coated onto 96-well microtiter plates, incubated with increasing concentrations of importin subunits, and bound importin-GST detected using a goat anti-GST primary antibody, an alkaline phosphatase-coupled rabbit anti-goat secondary antibody, and the substrate p-nitrophenyl phosphate (34). In experiments where importin alpha /beta combinations were tested, importin alpha -GST and thrombin-cleaved GST-free importin beta s were used. Absorbance measurements at A405 nm were performed over a 90-min period using a plate reader (Molecular Devices), with values corrected by subtracting absorbance both at 0 min and in wells incubated without importin (34). Quantitation was also performed in identical fashion for beta -galactosidase, and these values subtracted from those for the T-ag and N1N2-beta galactosidase fusion proteins (28, 34, 35). All fusion proteins were also subjected to a parallel beta -galactosidase ELISA (34) to correct for any differences in coating efficiencies and enable a true estimate of bound importin (28, 34, 35, 38).

In Vitro Nuclear Transport-- Nuclear import kinetics were measured at the single cell level using mechanically perforated HTC rat hepatoma cells in conjunction with confocal laser scanning microscopy as previously (31, 34, 35, 38). Experiments were performed for 40 min at room temperature in a 5 µl volume containing 30 mg/ml bovine serum albumin, 2 mM GTP, an ATP regenerating system (0.125 mg/ml creatine kinase, 30 mM creatine phosphate, 2 mM ATP), and transport substrate (0.2 mg/ml 5-iodoacetamidofluorescein-labeled fusion protein), or a control (70-kDa fluorescein isothiocyanate-labeled dextran; Sigma) to assess nuclear integrity. Where indicated, 4 µM RanGDP, 1 µM m-IMPbeta or y-IMPbeta , 1 µM m-IMPalpha or y-IMPalpha , and NTF2 (0.04-6 µM) were added. Image analysis and curve-fitting were performed as described (34, 35, 38); the level of accumulation at the nuclear envelope, relative to medium fluorescence, was measured using NIH Image 1.60 in the line plot mode, as previously (32, 39).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

y-IMPalpha Has Higher NLS Binding Affinity Than m- IMPalpha -- We have used an ELISA-based assay to determine the binding affinities of mouse importin subunits for different NLSs (28, 34, 35, 40), with the results revealing relatively low NLS-binding affinity for m-IMPalpha compared with that for the m-IMPalpha /beta heterodimer (28, 34). We set out to compare the NLS binding affinity of m-IMPalpha , y-IMPalpha , m-IMPalpha /beta , and y-IMPalpha /beta for proteins containing either the T-ag NLS, or the bipartite NLS of the X. laevis nuclear factor N1N2 (see Table I). y-IMPalpha bound these fusion proteins with significantly (p < 0.05) higher affinity (about 2-fold) than m-IMPalpha (Figs. 1 and 2; see Table II), the latter only attaining high affinity in the presence of m-IMPbeta . The specificity of binding in all cases was indicated by the fact that binding to NLS mutant derivatives was severely reduced (Table II). The T-ag NLS mutant showed negligible binding affinity for IMPalpha /beta from either mouse or yeast, whereas the two N1N2 NLS mutant derivatives showed different importin binding affinity (Fig. 2). N1N2A-beta -Gal, mutated in the proximal arm of the bipartite NLS, showed apparent dissociation constants (Kd values) of 48 and 35 nM for y-IMPalpha /beta and m-IMPalpha /beta , respectively, whereas N1N2A-beta -Gal, mutated in the distal arm, exhibited negligible binding. Clearly, mouse and yeast IMPalpha /beta are able to bind both types of NLS specifically, with y-IMPalpha binding with higher affinity than m-IMPalpha (Figs. 1 and 2; Table II).

                              
View this table:
[in this window]
[in a new window]
 
Table I
NLS sequences contained in the proteins used in this study
Fusion proteins contain the indicated amino acid sequences fused amino-terminal to E. coli beta -galactosidase (amino acid 9---1023) (see "Materials and Methods" and Refs. 30---32). The single letter amino acid code is used with small letters indicating variation from the wild type sequences (33).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   y-IMPalpha binds the T-ag NLS with higher affinity than m-IMPalpha as quantitated using an ELISA-based binding assay. Microtiter plates were coated with T-ag-CcN-beta -Gal or the NLS-deficient T-ag-Cc-beta -Gal, and incubated with increasing concentrations of m-IMPalpha (left panel) or y-IMPalpha (right panel) in the absence or presence of m-IMPbeta or y-IMPbeta as indicated. Curves were fitted for the function B(x) = Bmax (1 - e-kB), where x is the concentration of importin, and B is the level of importin bound, with the apparent dissociation constants (Kd values, representing the importin concentration yielding half-maximal binding) indicated. The results are from a single typical experiment performed in triplicate (S.D. not greater than 9% the value of the mean), with pooled data shown in Table II. UD, Kd unable to be determined due to low binding.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   y-IMPalpha binds the N1N2 NLS with higher affinity than m-IMPalpha . Measurements were performed as described in the legend to Fig. 1. Curves for wild type N1N2-beta -Gal (top panels), mutant derivatives N1N2A-beta -Gal (middle panels) and N1N2B-beta -Gal (bottom panels) are shown for m-IMPalpha (left panels) or y-IMPalpha (right panels) in the absence or presence of m-IMPbeta or y-IMPbeta as indicated. The results are from a single typical experiment performed in triplicate (S.D. not greater then 9% the value of the mean), with pooled data shown in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Binding parameters of NLS-containing beta -gatactosidase fusion proteins for yeast and mouse importins as measured using an ELISA-based assay
Sequence details are presented in Table I. Data represent the mean ± S.E. (number in parentheses) for the apparent dissociation constant (Kd) determined as outlined under "Materials and Methods" (28, 34).

Interestingly, the affinity of y-IMPalpha after precomplexation to y-IMPbeta for the T-ag NLS was not significantly different from that in its absence (Fig. 1 and Table II), but was enhanced 2-fold (p < 0.02) in the case of the N1N2 NLS (Fig. 2; Table II). This was in contrast to the significantly larger effect of m-IMPbeta on NLS recognition by m-IMPalpha (p < 0.03), where the presence of m-IMPbeta increased the binding affinity 2- and 4-fold for the T-ag and N1N2 NLSs respectively (Table II). Clearly, y-IMP alpha  is a higher affinity NLS receptor than m-IMPalpha , which requires m-IMPbeta to achieve high affinity. That y-IMPbeta increased the binding affinity of m-IMPalpha for the bipartite N1N2 NLS but not for the T-ag NLS implies that different NLSs have different requirements to achieve high affinity recognition by importin.

Nuclear Import Conferred by the T-ag NLS Does not Require NTF2-- The ability of m-IMPalpha /beta and y-IMPalpha /beta to mediate nuclear import in a reconstituted in vitro system was compared (Fig. 3). In the presence of RanGDP, y- or m-IMPalpha or beta  alone could not mediate nuclear import of T-ag-CcN-beta -Gal (data not shown) with the levels of nuclear accumulation similar to those in the absence of importin subunits (Fig. 3, A-C and Table III). This was in contrast to the combination of m-IMPalpha /beta where maximal nuclear accumulation relative to that in the cytoplasm (Fn/cmax) was about 5-fold, half-maximal levels (t1/2) being achieved within 5.3 min. In the presence of NTF2, the nuclear import rate was enhanced significantly (t1/2 = 2.6 min; p < 0.05), whereas Fn/cmax remained unaffected (Fn/cmax of 5.0; see Table III).


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 3.   Ability of y-IMPalpha /beta and m-IMPalpha /beta to mediate nuclear import of a T-ag NLS-containing protein or mutant variant in vitro using purified components in the absence or presence of NTF2. Nuclear import was reconstituted in mechanically perforated HTC cells in the presence of an ATP-regenerating system containing GTP/GDP and using GDP-loaded Ran as described under "Materials and Methods." A, visualization of binding at the nuclear envelope (top panels) or nuclear accumulation (middle panels) of the T-ag-NLS-containing fusion protein T-ag-CcN-beta -Gal, or lack of nuclear accumulation of the NLS-mutant derivative T-ag-Cc-beta -Gal (bottom panels) mediated by importin subunits in the absence or presence of Ran and NTF2 (0.08 µM) after 10 and 30 min, respectively. B, visualization at early time points of nuclear accumulation as indicated of T-ag-CcN-beta -Gal mediated by m-IMPalpha /beta (left panels) and y-IMPalpha /beta (right panels) in the presence of RanGDP in the absence (top panels) and presence (bottom panels) of NTF2. C, nuclear import kinetics of T-ag-CcN-beta -Gal and T-ag-Cc-beta -Gal mediated by m-IMPalpha /beta (left panel) or y-IMPalpha /beta (right panel) in the presence of Ran and NTF2 (0.08 µM). Results shown are from a single typical experiment where each data point represents at least five separate measurements for each of Fn, Fc, and background fluorescence (see "Materials and Methods"). Data is fitted for the function Fn/c = Fn/cmax(1 - e-kt), where Fn/cmax is the maximal level of nuclear accumulation, k is the rate constant, and t is time in minutes. Pooled data are presented in Table III.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Kinetics of nuclear import reconstituted in vitro using purified proteins
Results represent the mean ± S.E. from data (see Figs. 3C and 4C) fitted to the function Fn/c(t) = Fn/cmax*(1-e-kt), where Fn/cmax is the maximal level of nuclear accumulation, k is the rate constant, and t is time in minutes. NTF2 was used at the optimal concentration for nuclear accumulation (see Fig. 5).

In the absence of exogenously added NTF2, y-IMPalpha /beta mediated nuclear import to levels (Fn/cmax of 5.8; t1/2 = 4.9 min) only slightly higher than m-IMPalpha /beta , while in the presence of NTF2, both the import rate and the level of accumulation (Fn/cmax of 9.4; t1/2 = 1.8 min) were increased further (p < 0.05; see Table III). The specificity of transport in all cases was demonstrated by the fact that the T-ag-Cc-beta -Gal protein, containing a nonfunctional NLS, did not accumulate to any significant extent (Fig. 3, A and C, and Table III). The results thus demonstrate that both m-IMPalpha /beta and y-IMPalpha /beta can mediate nuclear import of an T-ag NLS-containing transport substrate independent of NTF2 (Fig. 3 and Table III).

We also examined the ability of m-IMPalpha /beta and y-IMPalpha /beta to mediate binding to the nuclear envelope in the absence of RanGDP/NTF2 (Fig. 3A, top panel). No targeting of T-ag-CcN-beta -Gal to the nuclear envelope could be observed in the absence of exogenously added importin subunits (results not shown). Although m-IMPalpha or beta  alone could not mediate binding, as expected, the combination of the two was able to do so with high efficiency (Fig. 3A). The maximal level of accumulation mediated by y-IMPalpha /beta at the nuclear envelope, as determined by image analysis using the line plot mode (39), was 4.6 ± 0.6 times higher than that in the cytoplasm, significantly higher (p < 0.008) than that effected by m-IMPalpha /beta of 2.4 ± 0.1 (n = 4). This activity, together with its higher affinity compared with m-IMPalpha /beta for the T-ag-NLS (Table II), is presumably the basis of the ability of y-IMPalpha /beta to mediate nuclear import more efficiently than m-IMPalpha /beta .

Nuclear Import Conferred by the N1N2 NLS Requires NTF2-- Nuclear import kinetic measurements were also performed using the bipartite NLS-containing substrate N1N2-beta -Gal (Fig. 4 and Table III). As for T-ag-CcN-beta -Gal, nuclear accumulation was negligible in the absence of either RanGDP or m-IMPalpha /beta . In the presence of m-IMPalpha /beta and RanGDP but in the absence of NTF2, a lack of nuclear accumulation was also evident, although nuclear accumulation was clearly observed in the presence of NTF2, with an Fn/cmax of 3.3 and t1/2 of 7.8 min.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 4.   Nuclear import of N1N2-beta -Gal and its mutant derivatives reconstituted in vitro mediated by m- IMPalpha /beta and y-IMPalpha /beta in the absence or presence of NTF2. A, visualization (after 30 min at room temperature) of nuclear accumulation of N1N2-beta -Gal and its mutant derivatives (N1N2A-beta -Gal and N1N2B-beta -Gal) mediated by m-IMPalpha /beta (left panels) or y-IMPalpha /beta (right panels) in the presence of RanGDP and NTF2. B, images after 30 min of nuclear accumulation of N1N2-beta -Gal mediated by m-IMPalpha /beta (left panels) and y-IMPalpha /beta (right panels) in the presence of RanGDP in the absence (top panels) and presence (bottom panels) of NTF2 (0.15 µM). C, nuclear import kinetics of N1N2-beta -Gal (top panels) or mutant derivatives N1N2A-beta -Gal (middle panels) and N1N2B-beta -Gal (bottom panels) mediated by m-IMPalpha /beta (left panels) or y-IMPalpha /beta (right panels) in the presence of RanGDP in the absence or presence of NTF2. Results shown are from a single typical experiment where each data point represents at least five separate measurements for each of Fn, Fc, and background fluorescence. Pooled data are presented in Table III.

Similar results were observed for y-IMPalpha /beta in the presence of Ran-GDP, no nuclear accumulation being observed in the absence of NTF2 (Fig. 4; Table III); in its presence y-IMPalpha /beta yielded an Fn/cmax of 4.2 (t1/2 = 4.1 min). Of the two N1N2-NLS mutant derivatives, N1N2A-beta -NLS was excluded from the nucleus, whereas N1N2B-beta -Gal showed reduced nuclear accumulation in the presence of RanGDP and NTF2 (Fn/cmax of 2.8, t1/2 = 13.9 min and Fn/cmax of 2.6, t1/2 = 8.4 min for y-IMPalpha /beta and m-IMPalpha /beta , respectively) compared with wild type N1N2-beta -gal. Clearly, although both arms of the bipartite N1N2 NLS are necessary for optimal nuclear import, mutation of the proximal arm has a much greater effect on nuclear import (Fig. 4) through its more severe effect on importin binding (Fig. 2).

Inhibition of Nuclear Import by High Levels of NTF2-- Previous studies have shown that NTF2 is necessary for nuclear import in several vertebrate systems, being able to bind directly to RanGDP, importin beta  and proteins of the NPC (15, 21, 41-44). Because the T-ag and N1N2 NLSs appeared to have different requirements for NTF2 for nuclear import, we performed transport measurements in the presence of increasing concentrations of NTF2 (Fig. 5). Although NTF2 concentrations up to 0.15-0.3 µM enhanced nuclear import of the T-ag NLS-containing fusion protein in the case of both m-IMPalpha /beta and y-IMPalpha /beta , higher concentrations inhibited transport strongly (Fig. 5A). Optimal nuclear import efficiency appeared to be obtained with an NTF2 concentration of about 0.08 µM.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Relationship between NTF2 concentration and nuclear import efficiency. Maximal nuclear accumulation (Fn/cmax) and import rate (t1/2, the time in min at which nuclear accumulation is half-maximal) is plotted against the NTF2 concentration for nuclear import of T-ag-CcN-beta -Gal (A) or N1N2-beta -Gal (B) mediated by m-IMPalpha /beta (left panels) or y-IMPalpha /beta (right panels) in the presence of Ran. Results are for the means ± S.E. from a series of three separate experiments.

Similar results were also observed for N1N2 NLS-mediated nuclear import (Fig. 5B), whereby m-IMPalpha /beta or y-IMPalpha /beta mediated import was enhanced in the presence of NTF2 concentrations up to 0.3 and 0.6 µM, respectively, with the optimal concentration of NTF2 for N1N2 NLS-mediated nuclear accumulation being about 0.15 µM. Nuclear accumulation was inhibited essentially completely by NTF2 concentrations above 0.6 µM. NTF2 thus appears to play a regulatory role in nuclear import, its concentration determining whether it has enhancing or inhibitory effects.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

This study represents the first quantitative comparison of two conventional NLS binding receptors and two different NLSs, and their ability to mediate nuclear protein import in a system using purified components. Although in vitro systems for nuclear transport have existed since 1990 (4), surprisingly little kinetic analysis has been performed. True understanding of the subtleties of signal-dependent nuclear import requires rigorous quantitation and this study can be seen as a first step in this direction. One of our important findings is that the importin alpha  subunits from mouse and yeast appear to be different in their requirement for importin beta  to achieve high affinity NLS binding. This is highlighted by the results for the T-ag NLS, where y-IMPalpha and y-IMPalpha /beta have almost identical binding affinities, in stark contrast to m-IMPalpha , which requires m-IMPbeta to obtain high affinity binding. In the case of the N1N2 NLS, y-IMPbeta does enhance y-IMPalpha binding, but not to such a great extent as the enhancement effected on m-IMPalpha binding by m-IMPbeta . y-IMPalpha thus appears to resemble importin alpha  from the plant Arabidopsis thalania to some extent, the latter being able to bind a variety of NLS types in the absence of importin beta  (32). There would thus appear to be a gradation through evolution in the properties of importin alpha , the vertebrate form being much more strongly dependent on the additional presence of importin beta  to achieve high affinity NLS binding.

As shown here, both y-IMPalpha /beta and m-IMPalpha /beta can mediate the nuclear import of proteins carrying the T-ag or N1N2 NLSs in combination with human Ran and NTF2, but the role of NTF2 in nuclear import of T-ag is different from that of N1N2. Nuclear import mediated by the T-ag NLS does not require NTF2 absolutely, whereas nuclear accumulation in the case of the N1N2 NLS is completely dependent on NTF2. Varying the concentration of NTF2 changes nuclear import dramatically, high levels of NTF2 inhibiting nuclear accumulation mediated by both the T-ag and N1N2 NLSs. This is consistent with the observations of Tachibana et al. (45), who found that cytoplasmically injected NTF2 strongly inhibited nuclear import mediated by the T-ag NLS, as well as nuclear export mediated by the nuclear export sequence of the cAMP-dependent protein kinase inhibitor PKI, in a dose-dependent manner. The basis of this may relate to the reported ability of NTF2 to regulate the functional size of the central transporter element of the NPC (46), as well as through its ability to associate with RanGDP, importin beta , and nucleoporins including p62 (14, 15, 41, 43, 44, 47), which itself is located close to the central channel of the NPC (48). The present study shows that the nuclear import process is finely balanced, with an individual NLS possessing its own particular properties and requirements with respect to the different nuclear transport components to be translocated to the nucleus with optimal efficiency. In this regard, NTF2 would appear to play a central regulatory role (42, 45-47, 49).

Our mutagenic analysis clearly shows that both arms of the N1N2 bipartite NLS are necessary for high affinity binding by importin alpha /beta as well as efficient nuclear targeting. Mutagenesis of the proximal arm of the NLS reduces importin binding and nuclear import, whereas mutation of the distal arm completely oblates both activities. Essentially similar results have been obtained for the nucleoplasmin NLS (50), our results thus confirming the bipartite nature of the N1N2 NLS (37). From our results here and elsewhere (28, 40), the importin binding and in vitro nuclear import of bipartite NLS-containing proteins appear to be intrinsically less efficient than those of proteins containing the T-ag NLS. Although T-ag may be rather special in terms of being a viral protein that uses the host cell transport system with unusually high efficiency, it remains unclear as to whether as yet unidentified transport factors may be involved in importin-mediated nuclear import of proteins carrying bipartite NLSs under physiological conditions. Investigation of this possibility is currently in progress in this laboratory.

The results presented here indicate a close relationship between the importin binding affinity and rate of nuclear import, where the highest affinity conformation of NLS and NLS receptor leads to the most efficient nuclear accumulation. This is illustrated most poignantly by the two different mutant variants of the N1N2 NLS, which exhibit quite different importin binding activities; the proximal arm mutant (the N1N2B-beta -Gal protein) is recognized by importins with higher affinity, and in consequence is able to be transported to the nucleus much more efficiently than the distal arm mutant (N1N2A-beta -Gal). NLS binding by importins is clearly a crucial step in nuclear import, consistent with the idea that the affinity of NLS recognition by importins is critical in determining the rate and maximal extent of NLS-dependent nuclear import (28, 34, 35, 40).

    ACKNOWLEDGEMENTS

We are indebted to Bryce Paschal, Mary Dasso, and Michael Rexach for providing the NTF2, Ran, and y-IMPalpha /beta expression constructs, respectively, and to Lyndall Briggs for skilled technical assistance.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Nuclear Signalling Laboratory, Division for Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia. Tel.: 00612-62494188; Fax: 00612-62490415; E-mail: David.Jans{at}anu.edu.au.

    ABBREVIATIONS

The abbreviations used are: NPC, nuclear pore complex; NLS, nuclear localization sequence; T-ag, SV40 large tumor antigen; GST, glutathione S-transferase; ELISA, enzyme-linked immunosorbent assay; IMP, importin; m-IMP, mouse IMP; y-IMP, yeast IMP.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
  1. Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. F. (1984) Nature 311, 33-38[Medline] [Order article via Infotrieve]
  2. Hall, N. M., Hereford, L., and Herskowitz, I. (1984) Cell 36, 1057-1065[Medline] [Order article via Infotrieve]
  3. Adam, S. A., and Gerace, L. (1991) Cell 66, 837-847[Medline] [Order article via Infotrieve]
  4. Adam, S. A., Sterne-Marr, R., and Gerace, L. (1990) J. Cell Biol. 111, 807-816[Abstract]
  5. Newmeyer, D. D., and Forbes, D. J. (1988) Cell 52, 641-653[Medline] [Order article via Infotrieve]
  6. Richardson, W. D., Mills, A. D., Dilworth, S. M., Laskey, R. A., and Dingwall, C. (1988) Cell 52, 655-664[Medline] [Order article via Infotrieve]
  7. Görlich, D., Prehn, S., Laskey, R. A., and Hartmann, E. (1994) Cell 79, 767-778[Medline] [Order article via Infotrieve]
  8. Görlich, D., Kostka, S., Kraft, R., Dingwall, C., R. A., Laskey, R. A., Hartmann, E., and Prehn, S. (1995) Curr. Biol. 5, 383-392[Medline] [Order article via Infotrieve]
  9. Imamoto, N., Shimamoto, T., Takao, T., Tachibana, T., Kose, S., Matsubae, M., Sekimoto, T., Shimonishi, Y., and Yoneda, Y. (1995) EMBO (EUR. MOL. BIOL. ORGAN.) J. 14, 3617-3626[Abstract]
  10. Chi, N. C., Adam, E. J. H., and Adam, S. A. (1995) J. Cell Biol. 130, 265-274[Abstract]
  11. Enenkel, C., Blobel, G., and Rexach, M. (1995) J. Biol. Chem. 270, 16499-16502[Abstract/Free Full Text]
  12. Melchior, F., Paschal, B., Evans, E., and Gerace, L. (1993) J. Cell Biol. 123, 1649-1659[Abstract]
  13. Moore, M. S., and Blobel, G. (1993) Nature 365, 661-663[CrossRef][Medline] [Order article via Infotrieve]
  14. Moore, M. S., and Blobel, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10212-10216[Abstract/Free Full Text]
  15. Paschal, B. M., and Gerace, L. (1995) J. Cell Biol. 129, 925-937[Abstract]
  16. Adam, E. J. H., and Adam, S. A. (1994) J. Cell Biol. 125, 547-555[Abstract]
  17. Krämer, D. M., Strambio de Castillia, C., Blobel, G., and Rout, M. P. (1995) J. Biol. Chem. 270, 19017-19021[Abstract/Free Full Text]
  18. Radu, A., Moore, M. S., and Blobel, G. (1995) Cell 81, 215-222[Medline] [Order article via Infotrieve]
  19. Görlich, D., Henkelein, P., Laskey, R. A., and Hartmann, E. (1996) EMBO (EUR. MOL. BIOL. ORGAN.) J. 15, 1810-1817[Abstract]
  20. Weis, K., Dingwall, C., and Lamond, A. I. (1996) EMBO (EUR. MOL. BIOL. ORGAN.) J. 15, 7120-7128[Abstract]
  21. Rexach, M., and Blobel, G. (1996) Cell 83, 683-692
  22. Tiganis, T., Flint, A. J., Adam, A. S., and Tonks, N. K. (1997) J. Biol. Chem. 272, 21548-21557[Abstract/Free Full Text]
  23. Lam, M. H. C., Briggs, L. J., Hu, W., Martin, T. J., Gillespie, M. T., and Jans, D. A. (1999) J. Biol. Chem. 274, 7391-7398[Abstract/Free Full Text]
  24. Pollard, V. W., Michael, W. M., Nakielny, S., Siomi, M. C., Wang, F., and Dreyfuss, G. (1996) Cell 86, 985-994[Medline] [Order article via Infotrieve]
  25. Aitchison, J. D., Blobel, G., and Rout, M. P. (1996) Science 274, 624-627[Abstract/Free Full Text]
  26. Rout, M. P., Blobel, G., and Aitchison, J. D. (1997) Cell 89, 715-725[Medline] [Order article via Infotrieve]
  27. Yaseen, N. R., and Blobel, G. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 4451-4456[Abstract/Free Full Text]
  28. Efthymiadis, A., Shao, H., Hübner, S., and Jans, D. A. (1997) J. Biol. Chem. 272, 22134-22139[Abstract/Free Full Text]
  29. Nadler, S. G., Tritschler, D., Haffar, O. K, Blake, J., Bruce, A. G., and Cleaveland, J. S. (1997) J. Biol. Chem. 272, 4310-4315[Abstract/Free Full Text]
  30. Rihs, H-P., Jans, D. A., Fan, H., and Peters, R. (1991) EMBO J. 10, 633-639[Abstract]
  31. Jans, D. A., Ackermann, M. J., Bischoff, J. R., Beach, D. H., and Peters, R. (1991) J. Cell Biol. 115, 1203-1212[Abstract]
  32. Hübner, S., Smith, H. M. S., Hu, W., Chan, C. K., Rihs, H-P., Paschal, B., Raikhel, N V., and Jans, D A. (1999) J. Biol. Chem., submitted
  33. Kleinschmidt, J. A., and Seiter, A. (1988) EMBO J. 7, 1605-1614[Abstract]
  34. Hübner, S., Xiao, C-Y., and Jans, D. A. (1997) J. Biol. Chem. 272, 17191-17195[Abstract/Free Full Text]
  35. Xiao, C.-Y., Hübner, S., and Jans, D. A. (1997) J. Biol. Chem. 272, 22191-22198[Abstract/Free Full Text]
  36. Chi, N. C., Adam, E. J. H., Visser, G. D., and Adam, S. A. (1996) J. Cell Biol. 135, 559-569[Abstract]
  37. Bradford, M. M. (1976) Anal. Biochem. 72, 258-254
  38. Efthymiadis, A., Briggs, L. J., and Jans, D. A. (1998) J. Biol. Chem. 273, 1623-1628[Abstract/Free Full Text]
  39. Piller, S. C., Jans, P., Gage, P. W., and Jans, D. A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 4595-4600[Abstract/Free Full Text]
  40. Briggs, L. J., Stein, D., Goltz, J., Corrigan, V. C., Efthymiadis, A., Hübner, S., and Jans, D. A. (1998) J. Biol. Chem. 273, 22745-22752[Abstract/Free Full Text]
  41. Paschal, B. M., Delphin, C., and Gerace, L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7679-7683[Abstract/Free Full Text]
  42. Paschal, B. M., Fritze, C., Guan, T., and Gerace, L. (1997) J. Cell Biol. 272, 2153-2159
  43. Nehrbass, U., and Blobel, G. (1996) Science 272, 120-122[Abstract]
  44. Stewart, M., Kent, H. M, and McCoy, A. J. (1998) J. Mol. Biol. 277, 635-646[CrossRef][Medline] [Order article via Infotrieve]
  45. Tachibana, T., Hieda, M., Sekimoto, T., and Yoneda, Y. (1996) FEBS Lett 397, 177-182[CrossRef][Medline] [Order article via Infotrieve]
  46. Feldherr, C., Akin, D., and Moore, M. S. (1998) J. Cell. Sci. 111, 1889-1896[Abstract/Free Full Text]
  47. Wong, D., Cobett, A. H., Kent, H. M., Stewart, M., and Silver, P. A. (1997) Mol. Cell. Biol. 17, 3755-3767[Abstract]
  48. Guan, T., Mueller, S., Klier, G., Pante, N., Blevitt, J. M., Haner, M., Paschal, B. M., Aebi, U., and Gerace, L. (1995) Mol. Biol. Cell 6, 1591-1603[Abstract]
  49. Clarkson, W. D., Cobett, A. H., Paschal, B. M., Kent, H. M., McCoy, A. J., Gerace, L., Silver, P. A., and Stewart, M. (1997) J. Mol. Biol. 272, 716-730[CrossRef][Medline] [Order article via Infotrieve]
  50. Robbins, J., Dilworth, S. M., Laskey, R. A., and Dingwall, C. (1991) Cell 64, 615-623[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.